Zobrazeno 1 - 10
of 11
pro vyhledávání: '"E B, Papadopoulos"'
Autor:
S M, Johnson Vickberg, K N, Duhamel, M Y, Smith, S L, Manne, G, Winkel, E B, Papadopoulos, W H, Redd
Publikováno v:
Psycho-oncology. 10(1)
The purpose of the present study was to examine global meaning (i.e. the belief that life has purpose and coherence) and psychological adjustment in survivors of bone marrow transplantation (BMT). Eighty-five survivors of BMT participated in a teleph
Autor:
D, Przepiorka, N A, Kernan, C, Ippoliti, E B, Papadopoulos, S, Giralt, I, Khouri, J G, Lu, J, Gajewski, A, Durett, K, Cleary, R, Champlin, B S, Andersson, S, Light
Publikováno v:
Blood. 95(1)
Daclizumab, a humanized monoclonal IgG1 directed against the alpha chain of the interleukin-2 receptor (IL-2R), is a competitive inhibitor of IL-2 on activated lymphocytes. To test the hypothesis that specific inhibition of activated lymphocytes in p
Autor:
T N, Small, E B, Papadopoulos, F, Boulad, P, Black, H, Castro-Malaspina, B H, Childs, N, Collins, A, Gillio, D, George, A, Jakubowski, G, Heller, M, Fazzari, N, Kernan, S, MacKinnon, P, Szabolcs, J W, Young, R J, O'Reilly
Publikováno v:
Blood. 93(2)
Unrelated bone marrow transplantation (BMT) is often complicated by fatal opportunistic infections. To evaluate features unique to immune reconstitution after unrelated BMT, the lymphoid phenotype, in vitro function, and life-threatening opportunisti
Autor:
E B, Papadopoulos, M H, Carabasi, H, Castro-Malaspina, B H, Childs, S, Mackinnon, F, Boulad, A P, Gillio, N A, Kernan, T N, Small, P, Szabolcs, J, Taylor, J, Yahalom, N H, Collins, S A, Bleau, P M, Black, G, Heller, R J, O'Reilly, J W, Young
Publikováno v:
Blood. 91(3)
Thirty-one consecutive patients with acute myelogenous leukemia (AML) in first complete remission and 8 with AML in second complete remission received T cell-depleted allogeneic bone marrow transplants from HLA-identical sibling donors. Patients rece
Publikováno v:
Important advances in oncology.
Autor:
J G, Jurcic, P C, Caron, T K, Nikula, E B, Papadopoulos, R D, Finn, O A, Gansow, W H, Miller, M W, Geerlings, R P, Warrell, S M, Larson
Publikováno v:
Cancer research. 55
M195, a mouse monoclonal antibody reactive with the early myeloid antigen CD33, has been shown to target leukemia cells in patients and to reduce large leukemic burdens when labeled with 131I. A complementarity-determining region-grafted, humanized v
Autor:
S, Mackinnon, E B, Papadopoulos, M H, Carabasi, L, Reich, N H, Collins, F, Boulad, H, Castro-Malaspina, B H, Childs, A P, Gillio, N A, Kernan
Publikováno v:
Blood. 86(4)
Infusions of large numbers (10(8)/kg) of donor leukocytes can induce remissions in patients with chronic myeloid leukemia (CML) who relapse after marrow transplantation. We wanted to determine if substantially lower numbers of donor leukocytes could
Publikováno v:
Bone marrow transplantation. 15(4)
We investigated the use of donor leukocytes for the treatment of Epstein-Barr virus (EBV) lymphoproliferative disease following T cell-depleted bone marrow transplantation (BMT) for chronic myeloid leukemia (CML). We wanted to determine whether donor
Autor:
J W, Young, E B, Papadopoulos, I, Cunningham, H, Castro-Malaspina, N, Flomenberg, M H, Carabasi, S C, Gulati, J A, Brochstein, G, Heller, P, Black
Publikováno v:
Blood. 79(12)
We prospectively evaluated the efficacy of T-cell-depleted bone marrow transplantation (BMT) in adults with de novo acute nonlymphocytic leukemia (ANLL) in first complete remission (CR), with regard to relapse-free survival and incidence of graft-ver
Autor:
N H, Collins, M H, Carabasi, S, Bleau, C, Jagiello, J W, Young, H, Castro-Malaspina, N, Flomenberg, E B, Papadopoulos, D, Emanuel, A, Gillio
Publikováno v:
Progress in clinical and biological research. 377